Transforming Diabetes Care: GlucosePATH Makes Personalized Medication Recommendations

Transforming Diabetes Care: GlucosePATH Makes Personalized Medication Recommendations

GlucosePATH uses computer science and clinical data to evaluate every possible treatment option, using data from the patient, FDA, and peer-reviewed journals, in just a few seconds. It was created by computer scientist Len Testa and endocrinologist Dr. Bradly Eilerman.

Len Testa is also co host of the fabulous Disney Dish podcast and the creator of Touring Plans the app and service of The Unofficial Guides to Walt Disney World, Disneyland and Disney Cruise Line. Testa is all about the math of theme parks – his guides are there to maximize the magic as he says – to make your waits shorter and save money – and it's all based on calculations from his team.

Disney very recently made some changes to their Disability Access Services program – often referred to as a DAS pass at Disney World and Disney Land. We're going to talk about why this happened, what it means for you, and what else is going on at Disney.

Note: this interview was taped BEFORE the changes took place.

More about Len Testa's Touring Plans here

More about the DAS changes here

We're also spending some time talking about a new service for doctors called Glucosepath and about a new surprising study about cortisol and diabetes. I'll also explain how these two guests can talk about all of these issues..

Dr. Eilerman also talks about the Catalyst study which looks at people with type 2 diabetes and measures cortisol.

This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

Please visit our Sponsors & Partners - they help make the show possible!

Learn about Dexcom

Check out US MED

Find out more about CeQur Simplicity

Check out VIVI Cap to protect your insulin from extreme temperatures

Learn more about AG1 from Athletic Greens

--

We have a monthly newsletter! Sign up today (no spam we promise)

Here's where to find us:

YouTube (new!)

Facebook (Group)

Facebook (Page)

Instagram

Threads

Check out Stacey's books!

Learn more about everything at our home page www.diabetes-connections.com

Reach out with questions or comments: info@diabetes-connections.com

Jaksot(59)

In the News.. Dexcom 15-day sensor update, TrialNet milestone, Beta Bionic IPO, and more!

In the News.. Dexcom 15-day sensor update, TrialNet milestone, Beta Bionic IPO, and more!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Dexcom updates investors on its 15-day sensor, TrialNet marks a big anniversary, Beta Bio...

25 Tammi 20257min

DiabeticU:  On a mission to build better support for people with type 2

DiabeticU: On a mission to build better support for people with type 2

Today on Diabetes Connections Type 2: Like a lot of people diagnosed with diabetes, Matthew Tremellen didn't feel like he got enough information, fast enough from his health care team. So he decided t...

22 Tammi 202526min

In the News... BIG beta cell transplant news, a new pump team-up, FDA moves on GLP-1 compounds, and more!

In the News... BIG beta cell transplant news, a new pump team-up, FDA moves on GLP-1 compounds, and more!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sana announces beta cell transplantation without the need for immunosuppresion drugs, Mod...

10 Tammi 20256min

In the News... Inhaled Insulin Studied for Kids, Dexcom Launches AI, App for Driving & T1D, and more!

In the News... Inhaled Insulin Studied for Kids, Dexcom Launches AI, App for Driving & T1D, and more!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Mannkind releases info about it's Afrezza pediatric studies, Dexcom launches AI tech with...

20 Joulu 20246min

In the News.. Defining T1D stages, InsuJet approval, T2D dementia risk and more!

In the News.. Defining T1D stages, InsuJet approval, T2D dementia risk and more!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: A push to change the defined stages of T1D, InsuJet is approved in Canada, new study link...

6 Joulu 20246min

Diabetes Digital: Bridging the gaps in type 2 care

Diabetes Digital: Bridging the gaps in type 2 care

Finding good diabetes info can be tough – there aren't enough endos and even if you have a great GP, a lot of information can fall through the cracks. More and more digital services and telehealth opt...

27 Marras 202427min

In the News... World Diabetes Day, Free T1D Care(?!), More Mounjaro info, New pump system, and more!

In the News... World Diabetes Day, Free T1D Care(?!), More Mounjaro info, New pump system, and more!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: World Diabetes Day roundup, existing drugs examined for T1D prevention, Blue Circle Healt...

15 Marras 20247min

In the News... Omnipod 5 iPhone update, Libre & Dexcom news, overnight insulin pump and more!

In the News... Omnipod 5 iPhone update, Libre & Dexcom news, overnight insulin pump and more!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: iPhone control for Omnipod 5 rolls out, Libre is approved for use in CT scans and MRIs, D...

1 Marras 20247min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
adhd-podi
rahapuhetta
rss-rahamania
kesken
psykologia
rss-liian-kuuma-peruna
rss-niinku-asia-on
rss-eron-alkemiaa
rss-arkea-ja-aurinkoa-podcast-espanjasta
esa-saarinen-filosofia-ja-systeemiajattelu
rss-duodecim-lehti
rss-vapaudu-voimaasi
rss-luonnollinen-synnytys-podcast
rss-tietoinen-yhteys-podcast-2
rss-finnish-daily-dialogues
ihminen-tavattavissa-tommy-hellsten-instituutti